160 related articles for article (PubMed ID: 10757121)
1. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
2. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
Zahalka MA; Okon E; Gosslar U; Holzmann B; Naor D
J Immunol; 1995 May; 154(10):5345-55. PubMed ID: 7537306
[TBL] [Abstract][Full Text] [Related]
3. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
4. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
Levesque MC; Haynes BF
J Immunol; 1996 Feb; 156(4):1557-65. PubMed ID: 8568260
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
6. The CD44 receptor of lymphoma cells: structure-function relationships and mechanism of activation.
Rochman M; Moll J; Herrlich P; Wallach SB; Nedvetzki S; Sionov RV; Golan I; Ish-Shalom D; Naor D
Cell Adhes Commun; 2000 Jan; 7(4):331-47. PubMed ID: 10714394
[TBL] [Abstract][Full Text] [Related]
7. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
Iida N; Bourguignon LY
J Cell Physiol; 1997 May; 171(2):152-60. PubMed ID: 9130462
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
[TBL] [Abstract][Full Text] [Related]
10. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
11. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
Lesley J; Hyman R
Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes.
Kryworuchko M; Diaz-Mitoma F; Kumar A
Exp Cell Res; 1999 Jul; 250(1):241-52. PubMed ID: 10388538
[TBL] [Abstract][Full Text] [Related]
13. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
Zarcone D; De Rossi G; Tenca C; Marroni P; Mauro FR; Cerruti GM; Albi N; Fiorucci S; Velardi A; Grossi CE
Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs.
Vogt Sionov R; Naor D
Int J Cancer; 1997 May; 71(3):462-9. PubMed ID: 9139885
[TBL] [Abstract][Full Text] [Related]
15. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
17. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
Hathcock KS; Hirano H; Murakami S; Hodes RJ
J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
[TBL] [Abstract][Full Text] [Related]
18. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.
Naor D; Wallach-Dayan SB; Zahalka MA; Sionov RV
Semin Cancer Biol; 2008 Aug; 18(4):260-7. PubMed ID: 18467123
[TBL] [Abstract][Full Text] [Related]
20. Trans-acting factors regulate the expression of CD44 splice variants.
Konig H; Moll J; Ponta H; Herrlich P
EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]